Razelle Kurzrock and Shumei Kato on Immunotherapy and Hyperprogression of Disease

09:00 EDT 15 Apr 2018 | Cancer Networks

Drs. Kato and Kurzrock discuss the potential reasons why some cancer patients experience hyperprogression of disease while on immunotherapy treatment.

More From BioPortfolio on "Razelle Kurzrock and Shumei Kato on Immunotherapy and Hyperprogression of Disease"